0.4833
price down icon1.94%   -0.0107
 
loading
Schlusskurs vom Vortag:
$0.494
Offen:
$0.47
24-Stunden-Volumen:
220.74K
Relative Volume:
0.47
Marktkapitalisierung:
$21.66M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-2.4165
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
-11.93%
1M Leistung:
-12.66%
6M Leistung:
+9.69%
1J Leistung:
-24.32%
1-Tages-Spanne:
Value
$0.459
$0.4906
1-Wochen-Bereich:
Value
$0.40
$0.5422
52-Wochen-Spanne:
Value
$0.2813
$0.9458

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Firmenname
Harvard Bioscience Inc
Name
Telefon
(508) 893-8999
Name
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Mitarbeiter
355
Name
Twitter
Name
Nächster Verdiensttermin
2026-03-12
Name
Neueste SEC-Einreichungen
Name
HBIO's Discussions on Twitter

Compare HBIO vs ISRG, BDX, ALC, RMD, MDLN

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
0.4844 22.09M 106.79M -8.73M 10.81M -0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
473.92 170.20B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
160.75 45.41B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
77.06 38.26B 10.40B 980.00M 1.61B 1.9749
Medical Instruments & Supplies icon
RMD
Resmed Inc
231.42 33.86B 5.40B 1.49B 1.78B 10.12
Medical Instruments & Supplies icon
MDLN
Medline Inc
41.12 33.33B 28.43B 1.16B 1.26B 1.4457

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-09 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2023-03-10 Hochstufung The Benchmark Company Speculative Buy → Buy
2021-01-07 Hochstufung The Benchmark Company Speculative Buy → Buy
2020-12-09 Eingeleitet Northland Capital Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-07-08 Herabstufung Janney Buy → Neutral
2018-01-24 Bestätigt Janney Buy
2018-01-23 Bestätigt The Benchmark Company Buy
2016-11-17 Eingeleitet Singular Research Buy
2015-07-28 Eingeleitet The Benchmark Company Buy
Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

pulisher
10:35 AM

HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus

10:35 AM
pulisher
08:31 AM

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey

08:31 AM
pulisher
08:25 AM

Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView

08:25 AM
pulisher
08:11 AM

Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com

08:11 AM
pulisher
02:38 AM

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com

02:38 AM
pulisher
Mar 12, 2026

Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience: Q4 Earnings Snapshot - Chron

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Earnings Transcript - AOL.com

Mar 12, 2026
pulisher
Mar 12, 2026

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Q4 & Annual Financial Results 2025News and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet

Mar 12, 2026
pulisher
Mar 12, 2026

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com

Mar 12, 2026
pulisher
Mar 12, 2026

HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph

Mar 12, 2026
pulisher
Mar 10, 2026

Harvard Bioscience promotes Frost to CFO - Worcester Business Journal

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks

Mar 10, 2026
pulisher
Mar 09, 2026

Harvard Bioscience Announces Reverse Stock Split - 富途牛牛

Mar 09, 2026
pulisher
Mar 08, 2026

Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq

Mar 08, 2026
pulisher
Mar 07, 2026

Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria

Mar 07, 2026
pulisher
Mar 07, 2026

Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com

Mar 06, 2026
pulisher
Mar 06, 2026

Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience announces reverse stock split - marketscreener.com

Mar 06, 2026
pulisher
Mar 06, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience to turn 10 shares into 1 in March split - Stock Titan

Mar 06, 2026
pulisher
Mar 05, 2026

Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World

Mar 05, 2026
pulisher
Mar 04, 2026

Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times

Mar 03, 2026
pulisher
Feb 26, 2026

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill

Feb 26, 2026
pulisher
Feb 26, 2026

Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 20, 2026

Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 15, 2026

What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

HBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

HBIO Should I Buy - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru

Feb 12, 2026

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$66.58
price up icon 0.57%
$166.75
price down icon 0.01%
medical_instruments_supplies COO
$70.65
price down icon 1.22%
$75.27
price up icon 0.09%
medical_instruments_supplies WST
$234.99
price up icon 1.57%
$41.15
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):